Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aldeyra Therapeu (NQ: ALDX )

3.260 USD UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 27, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Aldeyra Therapeu

< Previous 1 2 3 4 5 Next >
Aldeyra Therapeutics Announces Positive Top-Line Data from Phase 2 Dry Eye Chamber Clinical Trial of Reproxalap, an Investigational New Drug, Compared to Xiidra®
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company discovering and developing innovative therapies for the treatment of immune-mediated diseases, today announced positive... 
From Business Wire News Releases
Aldeyra Therapeutics to Participate in Fireside Chat at the H.C. Wainwright BioConnect Virtual Conference
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company discovering and developing innovative therapies for the treatment of immune-mediated diseases, today announced that Todd C.... 
From Business Wire News Releases
Aldeyra Therapeutics Completes Enrollment in Part 1 of the Phase 3 GUARD Trial of ADX-2191 in Proliferative Vitreoretinopathy
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company discovering and developing innovative therapies for the treatment of immune-mediated diseases, today announced completion of... 
From Business Wire News Releases
55 Biggest Movers From Yesterday
Gainers Reliance Global Group, Inc. (NASDAQ: RELI) shares jumped 78.7% to close at $5.45 on Tuesday after gaining around 6% on ... 
Tags PL NVEI BLIN
From Benzinga
Mid-Afternoon Market Update: Dow Jumps Over 500 Points; Rite Aid Shares Spike Higher
Toward the end of trading Tuesday, the Dow traded up 1.52% to 35,463.11 while the NASDAQ rose 2.10% to 15,295.45. The S&P also rose, ... 
Tags DBVT RAD Small Cap
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Jaguar Health (NASDAQ:JAGX) shares increased by 58.26% to $1.82 during Tuesday's regular session. Trading ... 
Tags Movers Benzinga SAVA
From Benzinga
Mid-Day Market Update: Crude Oil Rises 3%; Aldeyra Therapeutics Shares Slide
Midway through trading Tuesday, the Dow traded up 1.15% to 35,332.22 while the NASDAQ rose 0.94% to 15,122.12. The S&P also rose, ... 
Tags News TGA Intraday Update
From Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
Gainers Reliance Global Group, Inc. (NASDAQ: RELI) surged 126% to $6.91 after gaining around 6% on Monday. Biofrontera Inc. ... 
Tags ISO JAKK AERC
From Benzinga
Stocks Set to Snap Selloff, Dow Eyes Triple-Digit Pop
The major benchmarks look set to snap their three-day losing streak today, as investors reassess their anxieties over the fast-spreading omicron variant. 
Tags Stocks / Equities Market News
From TalkMarkets
The Daily Biotech Pulse: Aldeyra Sinks On Dry Eye Disease Readout, Sanofi Goes Shopping, Regulatory Setback For Aquestive, Aridis Touts Pan-Coronavirus Antibody Cocktail
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus CytomX Mid-Phase Study Of ... 
Tags Market News SNY PFE
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Aridis Pharmaceuticals (NASDAQ:ARDS) stock moved upwards by 75.98% to $4.47 during Tuesday's pre-market ... 
Tags BFRI AQST ARDS
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! We're kicking off the day with a dive into some of the biggest pre-market stock movers for Tuesday! The post Today’s... 
Tags ALDX ARDS AQST
From InvestorPlace
10 Biggest Price Target Changes For Tuesday
B of A Securities lifted the price target on Micron Technology, Inc. (NASDAQ: MU) from $76 to $100. Micron shares rose 7.7% to ... 
Tags Price Target Changes MU Small Cap
From Benzinga
26 Stocks Moving in Tuesday's Pre-Market Session
Gainers Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) rose 102% to $5.13 in pre-market trading after the company reported ... 
Tags Pre/Market Movers Markets MU
From Benzinga
Aldeyra's Dry Eye Disease Candidate Disappoints In Late-Stage Study
Aldeyra Therapeutics Inc(NASDAQ: ALDX)reported topline datafrom Phase 3 TRANQUILITY Trial of reproxalap ophthalmic ... 
Tags Trading Ideas Biotech Small Cap
From Benzinga
Aldeyra Therapeutics Announces Top-Line Results from the Phase 3 TRANQUILITY Trial in Dry Eye Disease
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra or the Company), a biotechnology company developing novel immune-modulating therapies to treat ocular and systemic diseases, today announced top-line... 
From Business Wire News Releases
Notable Thursday Option Activity: ALDX, INTC, AJRD
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Aldeyra Therapeutics Inc (ALDX), where a total volume of 3,549 contracts has been... 
Tags Stocks
From Market News Video
Noteworthy Wednesday Option Activity: ALLK, ALDX, DMRC
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Allakos Inc (ALLK), where a total volume of 3,180 contracts has been traded thus... 
Tags Stocks
From Market News Video
Noteworthy Tuesday Option Activity: HOG, ALDX, ACM
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Harley-Davidson Inc (HOG), where a total of 11,986 contracts have traded so far,... 
Tags Stocks
From Market News Video
Notable Wednesday Option Activity: IMVT, ALDX, CUE
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Immunovant Inc (IMVT), where a total of 7,785 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
Aldeyra Therapeutics to Participate in Upcoming Conferences
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra or the Company), a biotechnology company developing novel immune-modulating therapies to treat ocular and systemic diseases, today announced that Todd... 
From Business Wire News Releases
Aldeyra Therapeutics Announces Completion of Enrollment in Phase 3 TRANQUILITY Trial in Patients with Dry Eye Disease and Reiterates New Drug Application (NDA) Submission Guidance
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra or the Company), a biotechnology company developing novel immune-modulating therapies to treat ocular and systemic diseases, today announced... 
From Business Wire News Releases
Peek Under The Hood: VTWG Has 23% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Kiniksa Pharmaceuticals (NASDAQ:KNSA) stock increased by 16.73% to $14.86 during Tuesday's regular session. ... 
Tags ALDX BFRI MOTS
From Benzinga
Aldeyra's Dry Eye Disease Trial Meets Primary Endpoint, But Did Not Reach Statistical Significance
Aldeyra Therapeutics Inc's(NASDAQ: ALDX) reproxalap achieved the primary endpoint of ocular redness in the Phase 2 trial in ... 
Tags dry eye disease Small Cap Briefs
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Bone Biologics (NASDAQ:BBLG) shares rose 33.57% to $7.32 during Tuesday's pre-market session. The ... 
Tags GLYC ESPR BZI/TFM
From Benzinga
Aldeyra Therapeutics Announces Achievement of Primary Endpoint of Ocular Redness in Randomized, Double-Masked, Vehicle-Controlled Phase 2 Clinical Trial in Dry Eye Disease
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced achievement of the primary endpoint of ocular redness in a randomized, double-masked, vehicle-controlled Phase 2 clinical trial in... 
From Business Wire News Releases
Aldeyra Therapeutics (ALDX) Q3 2021 Earnings Call Transcript
ALDX earnings call for the period ending September 30, 2021. 
Tags ALDX Market News
From Motley Fool
The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Corvus' China Partner ... 
Tags GNCA BNTX Benzinga
From Benzinga
Aldeyra Therapeutics Reports Third-Quarter 2021 Financial Results and Recent Corporate Highlights
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company developing novel immune-modulating therapies to treat ocular and systemic diseases, today reported recent corporate... 
From Business Wire News Releases
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.